levoleucovorin and becatecarin

levoleucovorin has been researched along with becatecarin* in 1 studies

Reviews

1 review(s) available for levoleucovorin and becatecarin

Article	Year
Becatecarin (Helsinn Healthcare). IDrugs : the investigational drugs journal, 2005, Volume: 8, Issue:10 Helsinn Healthcare SA is developing becatecarin, a topoisomerase II inhibitor for the potential intravenous treatment of cancer. Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Clinical Trials as Topic; DNA Topoisomerases, Type II; Fluorouracil; Glucosides; Humans; Indoles; Leucovorin; Randomized Controlled Trials as Topic; Survival; Topoisomerase II Inhibitors	2005

Article

Year

IDrugs : the investigational drugs journal, 2005, Volume: 8, Issue:10

Helsinn Healthcare SA is developing becatecarin, a topoisomerase II inhibitor for the potential intravenous treatment of cancer.

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Clinical Trials as Topic; DNA Topoisomerases, Type II; Fluorouracil; Glucosides; Humans; Indoles; Leucovorin; Randomized Controlled Trials as Topic; Survival; Topoisomerase II Inhibitors

2005